XML 113 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans - Stock Based Compensation Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 19, 2022
Nov. 21, 2022
Oct. 31, 2022
Mar. 21, 2022
Mar. 02, 2022
Mar. 22, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jun. 06, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares authorized (in shares)                   7,949,996
Grants in period (in shares) 58,912   173,766 130,951   109,654 363,629 109,654    
Grants in period (in dollars per share) $ 6.79   $ 7.22 $ 6.51   $ 4.91        
Grants in period (in dollars per share)     $ 20.54 $ 21.79   $ 17.86 $ 21.08 $ 17.86    
Options exercised in period, intrinsic value             $ 1,800 $ 59,991    
Exercises in period (in shares)             315,703 28,522 0  
Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares authorized (in shares)                   2,271,427
Equity instruments other than options, grants in period (in shares) 18,984 13,722 38,730   51,746 50,203 123,182 50,203    
Equity instruments other than options, grants in period (in dollars per share) $ 21.07 $ 21.86 $ 20.54   $ 21.79 $ 17.86 $ 21.29 $ 17.86    
Share-based payment expense             $ 4,300 $ 5,700 $ 5,600  
Equity instrument other than options, nonvested (in shares)             430,954 1,054,335 1,263,169  
Nonvested award, excluding option, cost not yet recognized             $ 6,000      
Cost not yet recognized, period for recognition             1 year 9 months 18 days      
Stock Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares authorized (in shares)                   5,678,569
Award vesting period (in years) 1 year   3 years 3 years   3 years        
Share-based payment expense             $ 3,200 $ 3,200 $ 3,200  
Equity instrument other than options, nonvested (in shares)             1,623,998      
Nonvested award, excluding option, cost not yet recognized             $ 6,400      
Cost not yet recognized, period for recognition             2 years 7 months 6 days      
Expiration period (in years) 10 years   10 years 10 years   10 years        
Expected term 5 years 6 months   6 years 7 years   6 years        
Risk free interest rate 3.71%   4.19% 2.34%   1.11%        
Expected volatility rate 26.11%   26.25% 25.31%   25.98%        
Expected dividend rate 0.00%   0.00% 0.00%   0.00%        
Minimum | Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)             1 year      
Maximum | Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)             5 years      
Share-based Payment Arrangement, Tranche One | Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)             1 year      
Share-based Payment Arrangement, Tranche One | Stock Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years) 1 year   1 year 1 year   1 year